Body mass index predictive of sputum culture conversion among MDR-TB patients in Indonesia

International Journal of Tuberculosis and Lung Disease

Volumn 18, Issue 5, 2014, Pages

  Putri, Fauziah Asnely ^a   Burhan, E ^a,b   Nawas, A ^a,b   Soepandi, P Z ^a,b   Sutoyo, D K ^a,b   Agustin, H ^a,b   Isbaniah, F ^a,b   Dowdy, D W ^c  

^a Indonesia Persahabatan Hospital   (Indonesia)

^b UNIVERSITY OF INDONESIA   (Indonesia)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Hospital; Programmatic management of drug resistant tuberculosis; Severe underweight

Indexed keywords

AMIKACIN; CYCLOSERINE; ETHAMBUTOL; ETHIONAMIDE; KANAMYCIN; LEVOFLOXACIN; OFLOXACIN; PYRAZINAMIDE; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; BODY MASS; COHORT ANALYSIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENETIC PROCEDURES; HUMAN; INDONESIA; LINE PROBE ASSAY; LIQUID CULTURE; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANT TUBERCULOSIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEX DIFFERENCE; SPUTUM CULTURE; SPUTUM CYTODIAGNOSIS; UNDERWEIGHT; BODY WEIGHT; DIAGNOSIS; DRUG EFFECTS; EPIDEMIOLOGY; ISOLATION AND PURIFICATION; KAPLAN MEIER METHOD; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; NUTRITIONAL STATUS; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROPORTIONAL HAZARDS MODEL; RISK; RISK FACTOR; SEVERITY OF ILLNESS INDEX; SPUTUM; TIME; TREATMENT OUTCOME; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY;

ADULT; ANTITUBERCULAR AGENTS; BACTERIOLOGICAL TECHNIQUES; BODY MASS INDEX; FEMALE; HUMANS; INDONESIA; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; NUTRITIONAL STATUS; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SPUTUM; THINNESS; TIME FACTORS; TREATMENT OUTCOME; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY;

EID: 84899541814     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.13.0602     Document Type: Article

References (21)

1. World Health Organization. Global tuberculosis report, 2013. WHO/HTM/TB/2013.11. Geneva, Switzerland: WHO, 2013. http://apps.who.int/iris/ bitstream/10665/91355/1/9789241564656-eng.pdf. Accessed February 2014.
2. Ahuja SD, Ashkin D, Avendano M, et al. Multidrug-resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients. PLOS MED 2012; 9: e1001300.
3. Gandhi N R, Nunn P, Dheda K, et al. Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis. Lancet 2010; 375: 1830-1843.
4. World Health Organization Regional Office for South-East Asia. Tuberculosis control in the South-East Asia region: annual TB report 2013. New Delhi, India: WHO, 2013. http://www.searo.who.int/entity/tb/annual-tb-report- 2013.pdf. Accessed February 2014.
5. Mota P C, Carvalho A, Valente I, Braga R, Duarte R. Predictors of delayed sputum smear and culture conversion among a Portuguese population with pulmonary tuberculosis. Revista Portuguesa de Pneumologia 2012; 18: 72-79.
6. Jeremiah K. Predictors of sputum conversion among pulimonary tuberculosis patients in Mwanza, Tanzania. Bergen, Norway: University of Bergen, 2009.
7. Kurbatova E V, Gammino V M, Bayona J, et al. Predictors of sputum culture conversion among patients treated for multidrug-resistant tuberculosis. Int J Tuberc Lung Dis 2012; 16: 1335-1343.
8. Hafkin J, Modongo C, Newcomb C, et al. Impact of the human immunodeficiency virus on early multidrug-resistant tuberculosis treatment outcomes in Botswana. Int J Tuberc Lung Dis 2013; 17: 348-353.
9. Mupere E, Malone L, Zalwango S, et al. Lean tissue mass wasting is associated with increased risk of mortality among women with pulmonary tuberculosis in urban Uganda. Ann Epidemiol 2012; 22: 466-473.
10. Holtz T H, Sternberg M, Kammerer S, et al. Time to sputum culture conversion in multidrug-resistant tuberculosis: predictors and relationship to treatment outcome. Ann Intern Med 2000; 144: 650-659.
11. Zachariah R, Spielmann M P, Harries A D, Salaniponi F M L. Moderate to severe malnutrition associated with early death in patients with tuberculosis is a risk factor. Trans R Soc Trop Med Hyg 2002; 96: 291-294. (Pubitemid 34785068)
12. Podewils L J, Holtz T, Riekstina V, et al. Impact of malnutrition on clinical presentation, clinical course, and mortality in MDR-TB patients. Epidemiol Infect 2011; 139: 113-20.
13. Laserson K F, Thorpe L E, Leimane V, et al. Speaking the same language: treatment outcome definitions for multidrug-resistant tuberculosis. Int J Tuberc Lung Dis 2005; 9: 640-645. (Pubitemid 40826156)
14. De Kantor I N, Kim S J, Frieden T, et al. Laboratory services in tuberculosis control. Part II: Microscopy. Geneva, Switzerland: World Health Organization, 1998.
15. Spiegelman D, Hertzmark E. Easy SAS calculations for risk or prevalence ratios and differences. Am J Epidemiol 2005; 162: 199-200. (Pubitemid 41373523)
16. Qazi F, Khan U, Khowaja S, et al. Predictors of delayed culture conversion in patients treated for multidrug-resistant tuberculosis in Pakistan. Int J Tuberc Lung Dis 2011; 15: 1556-1559.
17. Lienhardt C, Manneh K, Bouchier V, Lahai G, Milligan P J M, McAdam K P W J. Factors determining the outcome of treatment of adult smear-positive tuberculosis cases in The Gambia. Int J Tuberc Lung Dis 1998; 2: 712-718. (Pubitemid 28429720)
18. PednekarMS, Hakama M, Hebert J R, Gupta P C. Association of body mass index with all-cause and cause-specific mortality: findings from a prospective cohort study in Mumbai (Bombay), India. Int J Epidemiol 2008; 37: 524-535. (Pubitemid 351804005)
19. Cegielski J P, Arab L, Cornoni-Huntley J. Nutritional risk factors for tuberculosis among adults in the United States, 1971-1992. Am J Epidemiol 2012; 176: 409-422.
20. Lönnroth K, Jaramillo E, Williams B G, Dye C, Raviglione M. Drivers of tuberculosis epidemics: the role of risk factors and social determinants. Soc Sci Med 2009; 68: 2240-2246.
21. Schwenk A, Hodgson L, Wright A, et al. Nutrient partitioning during treatment of tuberculosis: gain in body fat mass but not in protein mass. Am J Clin Nutr 2004; 79: 1006-1012. (Pubitemid 41095952)